NDC 82511-008 – Gemcitabine hydrochloride
Gemcitabine Hydrochloride 200 mg/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC82511-008
Product details
- Brand name
- Gemcitabine hydrochloride
- Generic name
- Gemcitabine hydrochloride
- Labeler
- Teyro Labs Private Limited
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA078759
- Marketed since
- August 8, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Active ingredients
- Gemcitabine Hydrochloride 200 mg/5mL
Uses, dosage, side effects and warnings for Gemcitabine hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 82511-008-20 | 1 VIAL, SINGLE-USE in 1 CARTON (82511-008-20) / 5 mL in 1 VIAL, SINGLE-USE | Aug 8, 2024 |
Other Gemcitabine hydrochloride products
- 68083-148 Gemcitabine Hydrochloride 200 mg/5mL · Injection, Powder, Lyophilized, For Solution · Gland Pharma Limited
- 68083-149 Gemcitabine Hydrochloride 1 g/25mL · Injection, Powder, Lyophilized, For Solution · Gland Pharma Limited
- 82511-009 Gemcitabine Hydrochloride 1 g/25mL · Injection, Powder, Lyophilized, For Solution · Teyro Labs Private Limited